Wednesday, May 8 • 1:00 pm – 5:00 pm
Thursday, May 9 • 8:00 am – Noon
ACEP Member: $150 │ Non-Member: $200
Opening speaker: Dr. Roneet Lev, Chief Medical Officer for the Office of National Drug Control Policy
This is your chance to complete the updated Emergency Medicine focused MAT training required to apply to the Drug Enforcement Agency for a waiver to prescribe buprenorphine. This is one of three medications, (buprenorphine, naltrexone and methadone), approved by the FDA for the treatment of opioid use disorder. Research demonstrates that MAT is effective in the treatment of opioid use disorders and can help some people to sustain recovery.
Funding for this initiative was made possible (in part) by grant no. 5U79TI026556-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
This course has been cancelled. If you had already registered, please contact email@example.com for information about a refund.